Scientific Evidence And E-Commerce Key To Seizing The Probiotic Opportunity

Exclusive: CEO of global probiotic firm BioGaia, Isabelle Ducellier, speaks to HBW Insight about the company's science- and e-commerce- based growth strategy.  

Bacterias 3D rendering
• Source: Shutterstock

Swedish probiotics specialist BioGaia AB is in a unique position to capitalize on the global probiotics trend, which has been boosted by the coronavirus pandemic, according to the firm’s CEO Isabelle Ducellier.

Speaking exclusively to HBW Insight, Ducellier pointed to BioGaia’s science-backed products and e-commerce success in the US and China as

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

Ceres Pharma Acquires Belgian Probiotics Player Vésale

 
• By 

Deal adds to Ceres' portfolio probiotic supplements in categories such as women's health and immunity marketed in Europe, Asia and North America.

Haleon Targets Low Income Households In Push To Reach 1bn More Consumers

 
• By 

Haleon wants to reach one billion more consumers by 2030 and plans to do this by tailoring products to those outside the highest income bracket. The UK-based firm's five-year growth plan will also see it generate £0.8bn in productivity savings.

People On The Move: Appointments At Haleon, Wellnex, Orkla

 
• By 

A round-up of the latest consumer health leadership changes: Haleon names Middle East & Africa unit manager; Wellnex Life appoints interim chair; Orkla Health appoints CEO.

Nestlé Health Science’s US VMS Recovery Stutters

 
• By 

US dietary supplement brand Nature's Bounty is yet to fully recover sales since supply issues forced it off shelves last year, according to Nestle's Q1 report.

More from Business